(22) found that the tumor PD-L1 was upregulated after treatment of RCC cell lines and RCC xenografts in nude mice with sunitinib, suggesting that immunosuppression of the tumor microenvironment may induce resistance to antiangiogenic treatment in metastatic RCC. This evidence concerns the gene CD274 and renal cell carcinoma.